[#item_full_content] Trulieve (NYSE:TRLV) posts wider margins and strong cash flow as Schedule III rescheduling removes a heavy federal tax burden on its medical cannabis business.
Read More
[#item_full_content] Trulieve (NYSE:TRLV) posts wider margins and strong cash flow as Schedule III rescheduling removes a heavy federal tax burden on its medical cannabis business.
Read More